Summary Yung Shin Pharma Ind Co Ltd (Yung Shin Pharma), a subsidiary of YungShin Global Holding Corporation is a distributor of veterinary drugs, diagnostic kits and active pharmaceutical drugs. The company’s products include carlipin, glix, macgel, diabetin, domper, kascoal, biotase, bisacodyl and anna film, among others. It offers products in the therapeutic areas of nervous system, circulatory system, respiratory system, digestive system, urinary tract, urogenital system, and others. Yung Shin Pharma collaborates with other pharmaceutical companies to develop new drugs. The company markets its products through its network of distributors. Yung Shin Pharma is headquartered in Taichung, Taiwan.
Yung Shin Pharma Ind Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Report Scope: The scope of this report includes an overview of the global market for nanomaterials in personalized medicine and analyses of global market trends, using 2019 as the base year and forecasting 2020 through 2025 with compound annual growth rate (CAGR) projections. The report is intended for professionals...
185 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Microfluidic Device Systems Market to Reach $10.7 Billion by 2027
- Amid the COVID-19 crisis, the global market for Microfluidic Device Systems estimated at US$3.1 Billion in the year 2020, is projected to reach a revised size of US$10.7 Billion by 2027, growing at a CAGR of 19.6% over the analysis...
430 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Battered Business Confidence Forces a -15% Decline in 2020. Global Market to Reach US$753.5Million by 2027
- The global market for Industrial X-Ray Inspection Systems is projected to reach a revised market size of US$753.5million by the year 2027 after posting a -15% decline in growth in the year 2020....
The Global Electronic Clinical Outcome Assessment Solution Market (eCOA) size is expected to reach $2.4 billion by 2026, rising at a market growth of 19% CAGR during the forecast period. Electronic clinical outcome assessment (eCOA) refers to a system that is capable of measuring mental state, patient symptom, and the prognosis of a disease....
Report Scope: This study focuses on the market side of research antibodies rather than the technical side.Different market segments for this specific market are covered. For example, application-based market segments include enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC),...
The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 report provides details of the latest distribution agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of distribution agreements from...
The Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010 - 2021 report is your one-stop source for providing real-deal information on hundreds of transactions, including the technology licensed, royalty rates, license fees, upfront and milestone payments. This report provides details of the latest partnering...
193 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Amaranth Oil Market to Reach $1.4 Billion by 2027
- Amid the COVID-19 crisis, the global market for Amaranth Oil estimated at US$682.2 Million in the year 2020, is projected to reach a revised size of US$1.4 Billion by 2027, growing at a CAGR of 10.5% over the analysis period 2020-2027. Cosmetic...
165 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Coenzyme Q10 Market to Reach $1.1 Billion by 2027
- Amid the COVID-19 crisis, the global market for Coenzyme Q10 estimated at US$602.8 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at a CAGR of 8.6% over the analysis period 2020-2027. Dietary Supplements,...
218 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Algae Products Market to Reach $48.9 Billion by 2027
- Amid the COVID-19 crisis, the global market for Algae Products estimated at US$35.5 Billion in the year 2020, is projected to reach a revised size of US$48.9 Billion by 2027, growing at a CAGR of 4.7% over the analysis period 2020-2027. Nutraceuticals,...
Pharmaceutical
World
China
United States
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.